Ann & Robert H. Lurie Children's Hospital of Chicago issued the following announcement on Dec. 5.
Patrick Seed, MD, PhD, was appointed President & Chief Research Officer of Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago. Since he joined Lurie Children’s in 2016, Dr. Seed has served as Associate Chief Research Officer for Basic Sciences at the Manne Research Institute and Division Head of Infectious Diseases at Lurie Children’s. He is the Children’s Research Fund Chair in Basic Science and Professor of Pediatrics, Microbiology and Immunology at Northwestern University Feinberg School of Medicine.
“Dr. Seed is an exceptional leader and scientist,” says Thomas Shanley, MD, President & CEO of Lurie Children’s. “I am confident that he will continue the remarkable trajectory of our research enterprise through his ability to identify and recruit exceptional talent, foster productive research collaborations, support professional development of our scientists and trainees, and drive advancement of our scientific discovery with an ever greater impact on pediatric medicine.”
Dr. Seed’s leadership has been instrumental to both the growth and evolution of the research institute. In the past four years, the Manne Research Institute more than doubled its research award funding from $34.7 million in fiscal year 2016 to $71.8 million in fiscal year 2020. In addition, he successfully co-navigated, with Cassandra Lucas, SMCRI COO, the complex move of the research institute a year ago from the Lincoln Park facility to the state-of-the-art Simpson Querrey Biomedical Research Center on the Streeterville campus, steps away from Lurie Children’s hospital.
In response to the COVID-19 pandemic, Dr. Seed developed new funding and led the scientific review process for granting seven institutional research awards that jump-started critical basic, translational, health systems, and population research into why COVID-19 is so aggressive, why children respond to the virus differently than adults, and how child and family health can be improved during and after the pandemic.
Dr. Seed also leads the Host-Microbial Interactions, Inflammation, and Immunity (HMI3) Program – one of the key research priorities of the Manne Research Institute. The program aims to advance knowledge about the molecular pathogenesis of infectious and inflammatory diseases and investigate how the microbiome contributes to immune and metabolic homeostasis and dysregulation. The goal of this research is to develop new diagnostics and therapies to improve health outcomes in children.
“I am honored to have the opportunity to lead our research enterprise,” says Dr. Seed. “We will build on the successes to date and work to maximize the impact of our youth-focused research across its translational spectrum, from basic science to population health.”
Dr. Seed succeeds Matthew Davis, MD, MAPP, as President & Chief Research Officer of the research institute. Dr. Davis, who served in the role beginning as interim in September 2019, will continue as Department Head of Medicine at Lurie Children’s and Chair of the Department of Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Davis also serves as Executive Vice President & Chief Community Health Transformation Officer, overseeing the Patrick M. Magoon Institute for Healthy Communities at Lurie Children’s.
“I am delighted to work with Dr. Seed in his new leadership role,” says Dr. Davis, “and I look forward to our ongoing partnership across the full spectrum of research efforts to advance the health of children, adolescents, and young adults across Chicagoland and beyond.”
Dr. Seed received both his doctorate in microbiology and his medical degree from the University of Rochester. He was a pediatric resident and chief resident at the University of Michigan, followed by a fellowship in infectious diseases at Washington University. He came to Lurie Children’s from Duke University.
Original source can be found here.
Alerts Sign-up